Markets:

Overview

News

Currencies

International

Treasuries

AVROBIO, Inc. - Common Stock (NQ:AVRO)

1.400 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AVROBIO, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML ↗

June 20, 2024

Palantir stock is on the rise Thursday as PLTR investors react to a new $19 million contract for the big data and AI company.

Via InvestorPlace

Topics Artificial Intelligence

Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today? ↗

June 20, 2024

NLS Pharmaceutics stock is down on Thursday as shares of NLSP come off of a recent rally that was fueled by heavy trading on Tuesday.

Via InvestorPlace

Why Is Avrobio (AVRO) Stock Moving Today? ↗

June 20, 2024

Avrobio stock is in the news Thursday as the company prepares for a merger and reverse stock split of AVRO after markets close today.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 20, 2024

Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning!

Via InvestorPlace

AVRO Stock Earnings: Avrobio Beats EPS for Q1 2024 ↗

May 13, 2024

AVRO stock results show that Avrobio beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Avrobio Shares Are Rising Wednesday ↗

July 12, 2023

AVROBIO Inc (NASDAQ: AVRO) shares are trading higher Wednesday after the company said it will explore strategic alternatives.

Via Benzinga

Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis ↗

May 22, 2023

Via Benzinga

AVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO

May 09, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), California BanCorp (Nasdaq – CALB)

February 26, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HireRight Holdings Corporation (NYSE – HRT), Kinnate Biopharma Inc. (Nasdaq – KNTE), AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB)

February 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO

February 14, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ZeroFox Holdings, Inc. (Nasdaq – ZFOX), AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB), Exro Technologies Inc. (OTC – EXROF)

February 06, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB), Exro Technologies Inc. (OTC – EXROF), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

January 30, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders

January 30, 2024

From Halper Sadeh LLC

Via Business Wire

AVROBIO and Tectonic Therapeutic Announce Merger

January 30, 2024

From AVROBIO, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 12, 2023

Via Benzinga

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 12, 2023

Via Benzinga

AVROBIO to Explore Strategic Alternatives

July 12, 2023

From AVROBIO, Inc.

Via Business Wire

AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million

June 12, 2023

From AVROBIO, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 07, 2023

Via Benzinga

Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis ↗

May 22, 2023

Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ: AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program...

Via Benzinga

Dow Tumbles 100 Points; Micron Technology Shares Plunge ↗

May 22, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping over 100 points on Monday. The Dow traded down 0.36% to 33,306.30 while the NASDAQ rose 0.39% to 12,707.21. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 22, 2023

Via Benzinga

Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher ↗

May 22, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded down 0.20% to 33,359.71 while the NASDAQ rose 0.47% to 12,717.37. The S&P...

Via Benzinga

Why Is AVROBIO (AVRO) Stock Up 83% Today? ↗

May 22, 2023

AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).

Via InvestorPlace

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 22, 2023

Via Benzinga

AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million

May 22, 2023

From AVROBIO, Inc.

Via Business Wire

Analyst Says Gene Therapy Data Update Offers Insights into Potential Pivotal Endpoints ↗

May 18, 2023

Avrobio Inc (NASDAQ: AVRO) shares are trading higher after the company announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.